DELAWARE KRATOM CONSUMER PROTECTION ACT: ATTEND MEETING & SUPPORT HB 332

Delaware has an opportunity to get kratom regulation right. HB 332, the Delaware Kratom Consumer Protection Act, is headed for a committee hearing this Wednesday, and consumer voices are needed now. This is not a ban. It is smart, science-based regulation that protects responsible adults while keeping natural kratom legal and accessible. Here's what you need to know and how to make your voice heard.

Take Action Now

Attending the hearing in person is the most powerful action you can take. Here is everything you need to show up:

• 📅 Wednesday, April 15 at 11:30 AM ET — Arrive by 11:00 AM
• 📍 House Chamber, Legislative Hall, 411 Legislative Ave, Dover, DE
• 🏛 House Health and Human Development Committee
• 🔗 Bill details: legis.delaware.gov/BillDetail?LegislationId=143020
• ⚡ Fastest action: globalkratomcoalition.org/advocacy-buddy
• 🔗 Full action toolkit: protectkratom.org/delaware

Attending In Person

• No registration needed
• Sign up on the paper sheet in the room for HB 332 (name and organization)
• Enter through the front doors, through security, then turn left
• Parking at the Archives building next door
• Oral testimony is approximately 1 to 2 minutes

Virtual Option

• Register in advance: legis.delaware.gov/MeetingNotice/33859
• Zoom/phone link provided after registration
• Virtual comments start after all in-person testimony
• Use "Raise Hand" in Zoom to be called on

Written Comments

• Email: HouseCommitteeComment@delaware.gov
• Subject: "HB 332 Kratom – April 15"
• Deadline: April 16 (accepted up to 24 hours after the hearing)

Priority Contacts — Reach These First, Individually

• Official Committee Comment Line — (302) 744-4351 | HouseCommitteeComment@delaware.gov
• Rep. Melanie Ross Levin — (302) 744-4351 | melanie.rosslevin@delaware.gov
• Nena Rapposelli — (302) 744-4351 | nena.rapposelli@delaware.gov

House Health and Human Development Committee — Email Each Member Individually

Phone for all members: (302) 744-4351

• Chair Rep. Nnamdi O. Chukwuocha — Nnamdi.Chukwuocha@delaware.gov
• Vice-Chair Rep. DeShanna U. Neal — Deshanna.Neal@delaware.gov
• Rep. Frank Burns — Frank.Burns@delaware.gov
• Rep. Kerri Evelyn Harris — KerriEvelyn.Harris@delaware.gov
• Rep. Debra Heffernan — Debra.Heffernan@delaware.gov
• Rep. Kendra Johnson — Kendra.Johnson@delaware.gov
• Rep. Eric Morrison — Eric.Morrison@delaware.gov
• Rep. Melanie Ross Levin — Melanie.RossLevin@delaware.gov
• Rep. Kamela T. Smith — Kamela.Smith@delaware.gov
• Rep. Claire Snyder-Hall — Claire.Snyder-Hall@delaware.gov
• Rep. Valerie Jones Giltner — Valerie.JonesGiltner@delaware.gov
• Rep. Kevin S. Hensley — Kevin.Hensley@delaware.gov
• Rep. Jeff Hilovsky — Jeff.Hilovsky@delaware.gov
• Rep. Charles S. Postles Jr. — Charles.Postles@delaware.gov
• Rep. Bryan W. Shupe — Bryan.Shupe@delaware.gov
• Rep. Michael F. Smith — Michael.F.Smith@delaware.gov

What to Say

Write and speak in your own words. Make these points:

• You support HB 332, the Delaware Kratom Consumer Protection Act
• This bill provides a responsible, science-based framework for regulating kratom, with age restrictions, product safety standards, and limits on synthetic compounds
• Natural kratom leaf is used responsibly by many adults, and policy should reflect the distinction between natural products and high-risk synthetic compounds
• You are asking them to support smart regulation over prohibition
• If kratom has supported your wellness, share your personal story, lawmakers remember real people

What HB 332 Would Do

HB 332 was introduced on March 26, 2026 by primary sponsor Rep. Ross Levin with co-sponsorship from Sen. Pinkney. The bill would amend Title 16 of the Delaware Code to establish a clear regulatory framework for kratom in the state. Key provisions include:

• Age restriction of 21+, prohibiting the distribution or sale of kratom products to anyone under 21
• Disclosure requirements, requiring anyone who prepares, distributes, sells, or advertises kratom products to disclose the factual basis for any claims made about the product
• Prohibitions on adulterated and mislabeled products, including labeling standards and restrictions on false or misleading advertising
• 7-OH concentration limits, targeting synthetic and enhanced products while keeping natural kratom accessible
• Civil violations for those who violate the prohibitions, creating enforceable accountability
• Reporting requirement, directing the Division of Alcohol and Tobacco Enforcement, in collaboration with the Delaware Healthcare Association, to report to the General Assembly by December 31, 2026 on adverse health events related to certain substances, including kratom, to help inform future regulatory decisions

This is exactly the kind of framework that 18 states have adopted through the Kratom Consumer Protection Act to protect consumers while keeping natural kratom accessible to responsible adults.

Why HB 332 Matters

Without a regulatory framework, Delaware's kratom market has no enforceable safety standards. That means no required lab testing, no age restrictions, no limits on synthetic alkaloids, and no label requirements to help consumers make informed choices. That is not a safe environment for consumers, and it is exactly the kind of gap that bad actors exploit.

The FDA has drawn a clear line between natural kratom and synthetic 7-OH products, identifying enhanced 7-hydroxymitragynine (7-OH) concentrates as the real public health concern, not natural kratom leaf. The AHPA has similarly warned against conflating 7-OH with natural kratom. As research discussed on the Huberman Lab podcast and confirmed by an FDA-supervised dosage study makes clear, these are fundamentally different products. HB 332 reflects that science. A ban would ignore it.

The Bigger Picture

States that have chosen regulation over prohibition have consistently produced better outcomes for consumers and public health alike. Delaware has a chance to join them on April 15. For the latest on kratom legality in Delaware and other states, visit our kratom legality map.

Show up on Wednesday. Register for the virtual option. Submit written comments. Delaware can set the right example with smart regulation, and it starts with this hearing.